484.75 +8.45 (1.77%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
466.75
Today’s High
493.95
52 Week Low
368.8
52 Week High
767.7
484.55 +8.30 (1.74%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
473.1
Today’s High
493.8
52 Week Low
368.55
52 Week High
769.15
Key Metrics
- Market Cap (In Cr) 4296.75
- Beta 1.32
- Div. Yield (%) 1.26
- P/B 2.25
- TTM P/E 14.52
- Peg Ratio 4.46
- Sector P/E 13.82
- D/E -
- Open Price 466.75
- Prev Close 476.3
Analysis
Price Analysis
-
1 Week-2.64%
-
3 Months19.17%
-
6 Month-11.03%
-
YTD-7.52%
-
1 Year-19.72%
Risk Meter
- 47% Low risk
- 47% Moderate risk
- 47% Balanced Risk
- 47% High risk
- 47% Extreme risk
Recos
7 Analysts
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- Strong Sell
- 0
- Sell
- 0
- Hold
- 0
- Buy
- 3
- Strong Buy
- 4
Sharda Cropchem News
Multibagger stock gets buy tag from Anand Rathi despite 400% rise in 3 years
2 min read . 25 Jan 2023
Buy or sell: Vaishali Parekh recommends 2 day trading stocks for today — Oct 7
1 min read . 07 Oct 2022
Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2022
- Total Revenue
- 3579.77
- Selling/ General/ Admin Expenses Total
- 297.02
- Depreciation/ Amortization
- 245.33
- Other Operating Expenses Total
- 1.13
- Total Operating Expense
- 3096.39
- Operating Income
- 483.38
- Net Income Before Taxes
- 464.24
- Net Income
- 349.25
- Diluted Normalized EPS
- 41.18
- Period
- 2022
- Total Assets
- 3743.13
- Total Liabilities
- 1830.67
- Total Equity
- 1912.46
- Tangible Book Valueper Share Common Eq
- 124.46
- Period
- 2022
- Cashfrom Operating Activities
- 267.1
- Cashfrom Investing Activities
- -207.89
- Cashfrom Financing Activities
- -90.96
- Net Changein Cash
- -28.86
- Period
- 2021
- Total Revenue
- 2395.61
- Selling/ General/ Admin Expenses Total
- 264.11
- Depreciation/ Amortization
- 170.44
- Other Operating Expenses Total
- 1.07
- Total Operating Expense
- 2110.88
- Operating Income
- 284.73
- Net Income Before Taxes
- 309.45
- Net Income
- 229.17
- Diluted Normalized EPS
- 28.55
- Period
- 2021
- Total Assets
- 2863.86
- Total Liabilities
- 1249.56
- Total Equity
- 1614.3
- Tangible Book Valueper Share Common Eq
- 106.38
- Period
- 2021
- Cashfrom Operating Activities
- 246.37
- Cashfrom Investing Activities
- -281.58
- Cashfrom Financing Activities
- 43.35
- Net Changein Cash
- 7.79
- Period
- 2020
- Total Revenue
- 2003.02
- Selling/ General/ Admin Expenses Total
- 233.5
- Depreciation/ Amortization
- 137.12
- Other Operating Expenses Total
- 0.89
- Total Operating Expense
- 1788.47
- Operating Income
- 214.54
- Net Income Before Taxes
- 184.87
- Net Income
- 164.66
- Diluted Normalized EPS
- 23.65
- Period
- 2020
- Total Assets
- 2347.22
- Total Liabilities
- 944.43
- Total Equity
- 1402.79
- Tangible Book Valueper Share Common Eq
- 94.53
- Period
- 2020
- Cashfrom Operating Activities
- 146.3
- Cashfrom Investing Activities
- -67.76
- Cashfrom Financing Activities
- -59.7
- Net Changein Cash
- 27.12
- Period
- 2019
- Total Revenue
- 2001.14
- Selling/ General/ Admin Expenses Total
- 214.8
- Depreciation/ Amortization
- 99.39
- Other Operating Expenses Total
- 0.82
- Total Operating Expense
- 1728.95
- Operating Income
- 272.2
- Net Income Before Taxes
- 235.02
- Net Income
- 176.34
- Diluted Normalized EPS
- 23.06
- Period
- 2019
- Total Assets
- 2203.35
- Total Liabilities
- 919.44
- Total Equity
- 1283.91
- Tangible Book Valueper Share Common Eq
- 78.24
- Period
- 2019
- Cashfrom Operating Activities
- 556.31
- Cashfrom Investing Activities
- -359.83
- Cashfrom Financing Activities
- -215.54
- Net Changein Cash
- -10.58
- Period
- 2018
- Total Revenue
- 1706.59
- Selling/ General/ Admin Expenses Total
- 182.58
- Depreciation/ Amortization
- 69.94
- Other Operating Expenses Total
- 0.8
- Total Operating Expense
- 1423.24
- Operating Income
- 283.35
- Net Income Before Taxes
- 287.19
- Net Income
- 190.77
- Diluted Normalized EPS
- 21.72
- Period
- 2018
- Total Assets
- 2226.21
- Total Liabilities
- 1091.39
- Total Equity
- 1134.82
- Tangible Book Valueper Share Common Eq
- 61.99
- Period
- 2018
- Cashfrom Operating Activities
- 16.96
- Cashfrom Investing Activities
- -162.84
- Cashfrom Financing Activities
- 132.26
- Net Changein Cash
- -10.97
- Period
- 2017
- Total Revenue
- 1399.23
- Selling/ General/ Admin Expenses Total
- 164.88
- Depreciation/ Amortization
- 56.26
- Other Operating Expenses Total
- 1.27
- Total Operating Expense
- 1140.99
- Operating Income
- 258.23
- Net Income Before Taxes
- 271.75
- Net Income
- 190.44
- Diluted Normalized EPS
- 21.27
- Period
- 2017
- Total Assets
- 1649.63
- Total Liabilities
- 689.79
- Total Equity
- 959.84
- Tangible Book Valueper Share Common Eq
- 57.62
- Period
- 2017
- Cashfrom Operating Activities
- 181.49
- Cashfrom Investing Activities
- -103.55
- Cashfrom Financing Activities
- -37.88
- Net Changein Cash
- 39.89
- Period
- 2022-12-31
- Total Revenue
- 1017.3
- Selling/ General/ Admin Expenses Total
- 12.63
- Depreciation/ Amortization
- 65.32
- Other Operating Expenses Total
- 102.81
- Total Operating Expense
- 888.11
- Operating Income
- 129.19
- Net Income Before Taxes
- 143.43
- Net Income
- 108.39
- Diluted Normalized EPS
- 12.01
- Period
- 2022-12-31
- Period
- 2022-12-31
- Period
- 2022-09-30
- Total Revenue
- 721.5
- Selling/ General/ Admin Expenses Total
- 8.55
- Depreciation/ Amortization
- 60.4
- Other Operating Expenses Total
- 84.89
- Total Operating Expense
- 678.21
- Operating Income
- 43.29
- Net Income Before Taxes
- 14.54
- Net Income
- 12.09
- Diluted Normalized EPS
- 1.34
- Period
- 2022-09-30
- Total Assets
- 3352.86
- Total Liabilities
- 1422.25
- Total Equity
- 1930.62
- Tangible Book Valueper Share Common Eq
- 114.32
- Period
- 2022-09-30
- Cashfrom Operating Activities
- 171.32
- Cashfrom Investing Activities
- -88.05
- Cashfrom Financing Activities
- -51.77
- Net Changein Cash
- 41.21
- Period
- 2022-06-30
- Total Revenue
- 824.53
- Selling/ General/ Admin Expenses Total
- 8.46
- Depreciation/ Amortization
- 54.73
- Other Operating Expenses Total
- 104.8
- Total Operating Expense
- 783.14
- Operating Income
- 41.39
- Net Income Before Taxes
- 17.64
- Net Income
- 22.64
- Diluted Normalized EPS
- 2.51
- Period
- 2022-06-30
- Period
- 2022-06-30
- Period
- 2022-03-31
- Total Revenue
- 1434.5
- Selling/ General/ Admin Expenses Total
- 12.74
- Depreciation/ Amortization
- 71.74
- Other Operating Expenses Total
- 106.98
- Total Operating Expense
- 1206.74
- Operating Income
- 227.75
- Net Income Before Taxes
- 220.47
- Net Income
- 176.97
- Diluted Normalized EPS
- 19.6
- Period
- 2022-03-31
- Total Assets
- 3743.13
- Total Liabilities
- 1830.67
- Total Equity
- 1912.46
- Tangible Book Valueper Share Common Eq
- 124.46
- Period
- 2022-03-31
- Cashfrom Operating Activities
- 267.1
- Cashfrom Investing Activities
- -207.89
- Cashfrom Financing Activities
- -90.96
- Net Changein Cash
- -28.86
- Period
- 2021-12-31
- Total Revenue
- 879.81
- Selling/ General/ Admin Expenses Total
- 10.84
- Depreciation/ Amortization
- 59.04
- Other Operating Expenses Total
- 93.63
- Total Operating Expense
- 744.94
- Operating Income
- 134.87
- Net Income Before Taxes
- 135.79
- Net Income
- 102.2
- Diluted Normalized EPS
- 11.33
- Period
- 2021-12-31
- Period
- 2021-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Technical
Moving Average
SMA
- 5 Day488.91
- 10 Day484.29
- 20 Day485.62
- 50 Day469.76
- 100 Day452.84
- 300 Day540.93
Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Tatva Chintan Pharma Chem
- 2054.15
- -13
- -0.63
- 2670
- 1953.75
- 4592.16
- PCBL
- 120.4
- 1.15
- 0.96
- 153.75
- 89.03
- 4495.58
- Sharda Cropchem
- 484.75
- 8.45
- 1.77
- 767.7
- 368.8
- 4296.75
- Meghmani Finechem
- 1050.4
- 23.45
- 2.28
- 1736.6
- 741.1
- 4271.98
- Rallis India
- 206.1
- 2.45
- 1.2
- 289.15
- 182.55
- 3973
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Tatva Chintan Pharma Chem
- 46.44
- 9.71
- -
- -
- PCBL
- 10.54
- 1.72
- 19.2
- 9.95
- Sharda Cropchem
- 11.56
- 2.25
- 16.16
- 9.5
- Meghmani Finechem
- 16.9
- 5.88
- -
- -
- Rallis India
- 23.17
- 2.34
- 13.09
- 8.11
Shareholding
- Category
- Percentage
- No. of shares
- Public Shareholding
- 25.18%
- 22,716,662
- HDFC SMALL CAP FUND
- 8.92%
- 8,048,834
- DSP EQUITY SAVINGS FUND
- 3.23%
- 2,911,005
- Others
- 0.32%
- 292,901
- Others
- 5.69%
- 5,129,403
- Others
- 2.58%
- 2,329,190
- Others
- 2.25%
- 2,029,911
- Others
- 1.13%
- 1,019,439
- Others
- 0.48%
- 435,985
- HUF
- 0.23%
- 208,735
- Clearing Members
- 0.04%
- 35,957
- Trusts
- 0%
- 1,144
- Others
- 0.16%
- 145,871
- Others
- 0.14%
- 127,690
- Others
- 0%
- 467
- Others
- 0%
- 130
- Promoter & Promoter Group Shareholding
- 74.82%
- 67,503,833
- ASHISH RAMPRAKASH BUBNA
- 16.83%
- 15,180,000
- MANISH RAMPRAKASH BUBNA
- 16.83%
- 15,180,000
- SHARDA RAMPRAKASH BUBNA
- 15.62%
- 14,091,147
- RAMPRAKASH VILASRAI BUBNA
- 15.58%
- 14,052,686
- SEEMA ASHISH BUBNA
- 4.99%
- 4,500,000
- ANISHA MANISH BUBNA
- 4.99%
- 4,500,000
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 24-Jan-23
- Quarterly Results & Interim Dividend
- 21-Oct-22
- Quarterly Results
- 25-Jul-22
- Quarterly Results
- 13-May-22
- Audited Results & Final Dividend
- 22-Jan-22
- Quarterly Results & Interim Dividend
- 26-Oct-21
- Quarterly Results
- 27-Jul-21
- Quarterly Results
- 26-May-21
- Audited Results & Final Dividend
- 25-Jan-21
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 02-Aug-22
- 28-Jun-22
- AGM
- 29-Jul-21
- 29-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 24-Jan-23
- 07-Feb-23
- 07-Feb-23
- 3
- 13-May-22
- 26-Jul-22
- 25-Jul-22
- 3
- 24-Jan-22
- 03-Feb-22
- 02-Feb-22
- 3
- 26-May-21
- 22-Jul-21
- 20-Jul-21
- 3
No recent bonus announcements.
No recent splits available.
No recent rights issue declared.
Company Profile
ABOUT Sharda Cropchem
- Industry Chemical Manufacturing
- ISIN INE221J01015
- BSE Code 538666
- NSE Code SHARDACROP
Sharda Cropchem Limited is an India-based agrochemicals company. The Company is principally engaged in export of agro chemicals and non-agro products to various countries across the world. The Company operates through two segments: Agrochemicals and Non Agrochemicals. Its Agrochemicals segment is engaged in the marketing and distribution of formulations and generic active ingredients across insecticides, herbicides, fungicides and biocides for protecting various kinds of crops as well as serves turf and specialty markets. Its Non Agrochemicals segment is engaged in the order-based procurement and supply of conveyor belts, V belts and timing belts, dyes and dye intermediates, and general chemical. It supplies its non-agro products to over 30 countries across Europe, North America, Latin America, Australia, and Asia. Its subsidiaries include Axis Crop Science Private Limited, Sharda Peru SAC, Sharda Del Ecuador CIA. Ltda., Sharda Polska SP. Z.O.O., Sharda Ukraine LLC and others.
MANAGEMENT
- Ramprakash Bubna Executive Chairman of the Board, Managing Director
- Ashok Vashisht Chief Financial Officer
- Jetkin Gudhka Chief Compliance Officer, Company Secretary
- Ashish Bubna Whole-time Director
- Manish Bubna Whole-time Director
- Sharda Bubna Whole-time Director
Company Summary
SHARDA CROPCHEM SUMMARY
Sharda Cropchem is trading 1.77% upper at Rs 484.75 as compared to its last closing price. Sharda Cropchem has been trading in the price range of 493.95 & 466.75. Sharda Cropchem has given -7.52% in this year & -2.64% in the last 5 days.
Sharda Cropchem has TTM P/E ratio 14.52 as compared to the sector P/E of 13.82. There are 7 analysts who have initiated coverage on Sharda Cropchem. There are 4 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 108.39 Crores in its last quarter.
Listed peers of Sharda Cropchem include Tatva Chintan Pharma Chem (-0.63%), PCBL (0.96%), Sharda Cropchem (1.77%) etc.
Sharda Cropchem has a 74.82% promoter holding & 25.18% public holding.
FAQs about Sharda Cropchem
Sharda Cropchem is trading at 484.75 as on 2 Feb, 2023 3:29:29 PM. This is 1.77% upper as compared to its previous closing price of 476.3
The market capitalization of Sharda Cropchem is 4296.75 Cr as on 2 Feb, 2023 3:29:29 PM.
The average broker rating on Sharda Cropchem is Strong Buy. The breakup of analyst rating is given below -
- 0 analysts have given a strong sell rating
- 0 analysts have given a sell rating
- 0 analysts have given a hold rating
- 3 analysts have given a buy rating
- 4 analysts have given a strong buy rating
The 52 wk high for Sharda Cropchem is 767.7 whereas the 52 wk low is 368.8
Sharda Cropchem can be analyzed on the following key metrics -
- TTM P/E: 14.52
- Sector P/E: 13.82
- Dividend Yield: 1.26%
- D/E ratio: -
Sharda Cropchem reported a net profit of 349.25 Cr in 2022.
